| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/10/2003 | US20030068387 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 04/10/2003 | US20030068378 Mucosal surface-coat-forming film dosage units containing a water-soluble hydrocolloid, an effective dose of a sexual dysfunction active agent and a mucosal adhesion enhancer, wherein mucosal adhesion enhancer is a starch graft copolymer |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2462661A1 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/10/2003 | CA2462538A1 Process for the fractionation of oilseed press cakes and meals |
| 04/10/2003 | CA2462427A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | CA2461596A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | CA2461560A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/10/2003 | CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | CA2460589A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460168A1 4¬piperidin-4-yliden-(3-carbamoylphenyl)methyl| benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | CA2460167A1 Aqueous ecabet sodium solution preparation |
| 04/10/2003 | CA2460006A1 Methods and compositions for treating or preventing bacterial infection |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | CA2425363A1 Benzimidazole compounds, process for producing the same and use thereof |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300412A1 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 04/09/2003 | EP1300407A1 Carbamates derived from arylalkylamines |
| 04/09/2003 | EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 04/09/2003 | EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 04/09/2003 | EP1300141A1 Medical composition kit for treating lesioned abnormal tissue |
| 04/09/2003 | EP1299548A1 Novel therapeutic molecular variants and uses thereof |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299424A1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 04/09/2003 | EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299357A1 Novel compounds |
| 04/09/2003 | EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives |
| 04/09/2003 | EP1299157A1 Composition and applicator for topical substance delivery |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299097A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol |
| 04/09/2003 | EP1299092A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 04/09/2003 | EP1299089A2 Drug delivery system for poorly water soluble drugs |
| 04/09/2003 | EP1299010A1 Vitamin k and essential fatty acids |
| 04/09/2003 | EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1149090B1 Novel crystalline form of the potassium salt of (s)-omeprazole |
| 04/09/2003 | EP0946547B1 A novel compound form |
| 04/09/2003 | EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives |
| 04/09/2003 | EP0806940B1 Aerosol drug formulations |
| 04/09/2003 | EP0724439B1 Use of 2-(2alkylphenylamino)oxazolines and -thiazolines for the manufacture of a medicament with alpha 2 adrenergic effect |
| 04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409716A New amino propylphosphinic acid |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409713A Fused heterotricyclic compound, process for preparing compounds and drugs containing the same |
| 04/09/2003 | CN1409712A Pyrrolo [2,3-d] pyrimidine compounds |
| 04/09/2003 | CN1409706A Calcium salts of 1,5-benzodiazepine derivatives, process for producing salts and drugs containing same |
| 04/09/2003 | CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder |
| 04/09/2003 | CN1409636A Use of honey in medical dressings |
| 04/09/2003 | CN1409634A Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| 04/09/2003 | CN1409605A Method for increasing pet activity |
| 04/09/2003 | CN1409587A Method for forming holes, using flexible connection board formed thereof and its producing method |
| 04/09/2003 | CN1408438A Gene vaccine based on macrophage colony stimulating factor recepter and its use |
| 04/09/2003 | CN1408427A Reduced type glutathione lozenge |
| 04/09/2003 | CN1408423A Medicine for curing hepatitis B |
| 04/09/2003 | CN1408422A Chinese herbal medicine for curing periodontitis and gingivitis |
| 04/09/2003 | CN1408413A Pellet capable of curing infantile anorexia and convulsion |
| 04/09/2003 | CN1408407A Asafoetide and eclipta capsule |
| 04/09/2003 | CN1408405A Medicne or health article containing behen vegetable |
| 04/09/2003 | CN1408383A Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method |
| 04/09/2003 | CN1408381A Bear gall, liver protecting oral liquor and its producing method |
| 04/09/2003 | CN1408375A Medicine for curing hepatitis B |
| 04/09/2003 | CN1408374A Medicine for curing hepatitis B |
| 04/09/2003 | CN1408373A Medicine for resisting senility, shrinking vagina, beautifying breast and stregthening male genitals and its production method |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/09/2003 | CN1104904C Natural tea for taking off the offect of drink and process for production thereof |
| 04/09/2003 | CN1104903C Medicine for treating hepatitis and productive process thereof |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor |
| 04/09/2003 | CN1104884C Storage stable dentifrice composition containing casein saccharide large molecular peptide |
| 04/09/2003 | CN1104844C Oral composition for animals |
| 04/08/2003 | WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 04/08/2003 | US6545182 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545050 Aryl sulphonamide amino acid esters and analogues |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545021 Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6545008 Pyrimidine derivatives and processes for the preparation thereof |
| 04/08/2003 | US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/08/2003 | US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity. |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6545002 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy |
| 04/08/2003 | US6544997 E.g., hypermotility, irritable bowel syndrome, bowel hypersensitivity and the reduction of pain associated with gastrointestinal hypersensitivity and/or hyperactivity |